Table 3.
Evolution of lesions after treatments, n = patients, n/32 = (%) | |||||
---|---|---|---|---|---|
New lesion | Relapses | ||||
Patients | Doses | Remission, weeks | Patients | Doses | Remission, weeks |
SRa 4 (12.5) | None | 8.50 ± 3.41 | 3 (9.37) | None | 4.7 ± 3.0 |
1 (3.12) | 10, Glub | 10 | |||
Glub 7 (21.87) | 27.4 ± 16.1 | 8.71 ± 2.49 | 4 (12.5) | None | 6.33 ± 1.52 |
3 (9.37) | 25 ± 10, Glub | 6.5 ± 3.79 |
aSR: spontaneous remission. bGlu: meglumine antimoniate or Glucantime.